Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries
| dc.rights.license | open | en_US |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | CAMBON, Linda | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | SCHWARZINGER, Michael | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | ALLA, Francois | |
| dc.date.accessioned | 2022-01-13T09:10:44Z | |
| dc.date.available | 2022-01-13T09:10:44Z | |
| dc.date.issued | 2022-01-21 | |
| dc.identifier.issn | 1873-2518 (Electronic) 0264-410X (Linking) | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/124366 | |
| dc.description.abstractEn | France is one of the most vaccine-hesitant countries in the world, including for coronavirus disease 2019 (COVID-19). After 10 months of restrictive measures and media coverage of the dangers of COVID-19, French attitudes towards a vaccine continue to deteriorate. The communication strategies of the government have not helped; in fact, they have made the situation worse. Empirical studies on the national strategy for management of the COVID-19 pandemic in France have shed light on the reasons for vaccine hesitancy. These studies have identified four pillars for the vaccination strategy: i) Communication regarding the importance of herd immunity, ii) making healthcare workers the focus of the vaccination campaign, iii) citizen mobilization and guaranteed consultations, and iv) access to free vaccines without delay. This paper discusses the evidence supporting this strategy. | |
| dc.description.sponsorship | Etude des leviers permettant de maximiser la vaccination contre la Covid-19 dans la population adulte âgée de 18 à 64 ans à faible risque d'infection sévère - ANR-21-CO16-0006 | en_US |
| dc.language.iso | EN | en_US |
| dc.subject.en | Models | |
| dc.subject.en | Vaccine hesitancy | |
| dc.subject.en | France | |
| dc.subject.en | Covid-19 | |
| dc.title.en | Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries | |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.vaccine.2021.11.023 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
| dc.identifier.pubmed | 34863619 | en_US |
| bordeaux.journal | Vaccine | en_US |
| bordeaux.page | 178-182 | en_US |
| bordeaux.volume | 40 | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.issue | 2 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | PHARES_BPH | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Agence Nationale de la Recherche | en_US |
| hal.identifier | hal-03524174 | |
| hal.version | 1 | |
| hal.date.transferred | 2022-01-13T09:10:46Z | |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Vaccine&rft.date=2022-01-21&rft.volume=40&rft.issue=2&rft.spage=178-182&rft.epage=178-182&rft.eissn=1873-2518%20(Electronic)%200264-410X%20(Linking)&rft.issn=1873-2518%20(Electronic)%200264-410X%20(Linking)&rft.au=CAMBON,%20Linda&SCHWARZINGER,%20Michael&ALLA,%20Francois&rft.genre=article |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||